WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest
WASHINGTON – Food Marketing Institute (FMI) on Friday participated in the Food and Drug Administration’s (FDA) public hearing regarding products containing cannabis or cannabis-derived compounds, including hemp and cannabidiol (CBD), as the agency considers whether and how to create a legal pathway for such products. FMI both conveyed the seriousness of the regulatory ambiguity facing its
CHICAGO — Chain Drug Review conducted a CBD Roundtable at the recent ECRM Cough/Cold Show at the Sheraton Grand Hotel. Participating in the panel discussion were: Dave Donnan, senior partner, A.T. Kearney. Vincent Porpiglia, president of Hero Brands, internal sales arm for Select CBD. Dave Janowicz, vice president of merchandising and retail operations, Pharmaca. Dr.
BOULDER, Colo. — Weller, an innovative pioneer in CBD-infused food and beverage products, announces today the launch of its first product line: CBD Coconut Bites, available in Dark Chocolate, Caramel and Original flavor varieties. “Consumers are over-scheduled and stressed now more than ever,” said Matt Oscamou, co-founder of Weller. “Weller is all about enabling people
